BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 2:47:00 PM | Browse: 856 | Download: 919
 |
Received |
|
2013-10-10 13:07 |
 |
Peer-Review Started |
|
2013-10-11 14:35 |
 |
To Make the First Decision |
|
2013-10-21 11:09 |
 |
Return for Revision |
|
2013-10-23 19:28 |
 |
Revised |
|
2013-10-30 01:01 |
 |
Second Decision |
|
2014-01-06 20:16 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-06 20:33 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-03-25 19:58 |
 |
Typeset the Manuscript |
|
2014-04-23 08:13 |
 |
Publish the Manuscript Online |
|
2014-04-24 19:19 |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Topic Highlights |
Article Title |
Duration of dual antiplatelet treatment in the era of next generation drug-eluting stents
|
Manuscript Source |
Invited Manuscript |
All Author List |
Seung-Woon Rha |
Funding Agency and Grant Number |
|
Corresponding Author |
Seung-Woon Rha, MD, PhD, FACC, FAHA, FESC, FSCAI, Cardiovascular Center, Korea University Guro Hospital, 80, Guro-dong, Guro-gu, Seoul 152-703, South Korea. swrha617@yahoo.co.kr |
Key Words |
Drug-eluting stent; Dual antiplatelet treatment; Percutaneous coronary intervention |
Core Tip |
Recently published important pivotal reports regarding the optimal duration of dual antiplatelets following drug-eluting stent implantation are summarized. |
Publish Date |
2014-04-24 19:19 |
Citation |
Rha SW. Duration of dual antiplatelet treatment in the era of next generation drug-eluting stents. World J Cardiol 2014; 6(4): 148-153 |
URL |
http://www.wjgnet.com/1949-8462/full/v6/i4/148.htm |
DOI |
http://dx.doi.org/10.4330/wjc.v6.i4.148 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345